Skip to main content
# Title Department Research Year
841 Densitometric method for simultaneous Det. of a binary mix. of meropenem and metronidazole or meropenem and secnidazole in pure and pharm formulation. Department of Pharmaceutical Analytical Chemistry 2018
842 Glibenclamide Mini-tablets with an Enhanced Pharmacokinetic and Pharmacodynamic Performance Department of Industrial Pharmacy 2018
843 Modified Lidocaine Derivatives as a Potential Inhibitors of Eosinophils Department of Medicinal Chemistry 2018
844 Enhanced dispersive solid phase extraction assisted by cloud point strategy prior to fluorometric determination of anti-hepatitis C drug velpatasvir in pharmaceutical tablets and body fluids Department of Pharmaceutical Analytical Chemistry 2018
845 Secondary Metabolites From the Fungus Quambalaria cyanescens Department of Pharmacognosy 2018
846 A rapid Fourier transform infrared spectroscopic method for analysis of certain proton pump inhibitors in binary and ternary mixtures Department of Pharmaceutical Analytical Chemistry 2018
847 Novel N-Substituted 5-aminosalicylamides as Dual Inhibitors of Cyclooxygenase and 5-Lipoxygenase Enzymes: Synthesis, Biological Evaluation and Docking Study 2018
848 Simultaneous quantitation of two direct acting hepatitis C antivirals (sofosbuvir and daclatasvir) by an HPLC-UV method designated for their pharmacokinetic study in rabbits Department of Pharmaceutical Analytical Chemistry 2018
849 Simultaneous quantitation of direct acting hepatitis c antiviral binary mixture via efficient HPLC-dual wavelength detection method Department of Pharmaceutical Analytical Chemistry 2018
850 ε-MnO2-modified graphite electrode as a novel electrochemical sensor
for the ultrasensitive detection of the newly FDA approved Hepatitis C
antiviral drug ledipasvir
2018